A significant clinical trial conducted by researchers from Mass General Brigham has revealed that the drug evolocumab can substantially decrease the risk of first heart attacks...
A recent study has demonstrated that Amgen’s cholesterol-lowering injection, Repatha, significantly reduces the risk of heart attacks and strokes in high-risk individuals who have not previously...
